b'B e i G e n eE i s a iBeiGeneis a global, commercial-stage biotechnologyAtEisai Inc. ,human health care (hhc) is our goal.company focused on discovering, developing,We give our first thoughts to patients and their manufacturing, and commercializing innovativefamilies, and helping to medicines to improveincrease the benefits health treatment outcomescare provides. As the U.S. and access for patientspharmaceutical subsidiary worldwide. Our 9,000+of Tokyo-based Eisai Co., employees around the world are committed toLtd., we have a passionate commitment to patient care expediting the development of a diverse pipeline that is the driving force behind our efforts to discover of novel therapeutics. and develop innovative therapies to help address unmet medical needs.See our ad on page 58 Eisai is a fully integrated pharmaceutical business that operates in two global business groups: oncology and neurology (dementia-related diseases and neurodegenerative diseases). Our U.S. headquarters, commercial and clinical development organizations are located in New Jersey; our discovery labs are in Massachusetts and Pennsylvania; and our global demand chain organization resides in Maryland and North Carolina. To learn more about Eisai Inc.,please visit us at www.eisai.com/US andfollow us on Twitter and LinkedIn.See our ad on page 106THE ADVERTISER GUIDEthe directory185'